Mandibular Osteonecrosis Induced by Bisphosphonates in a Carrier of Chronicle Kidney Disease
Contenido principal del artículo
Resumen
The bisphosphonates are synthetic substances of inorganic pyrophosphate that have been the basis of treatment of patients with osteolytic diseases, such as multiple myeloma, malignant hypercalcemia, Paget's disease, or patients with bone metastases. Its main pharmacological effect is inhibition of bone resorption caused by osteoclasts, which have a reduced function. Their adverse effects are infrequent but include pyrexia, impaired renal function, hypocalcemia, and more recently, maxillo-mandibular ostenecrose induced bofosfonatos. In this report we describe a clinical case of jaw osteonecrosis induced by bisphosphonates in patient with chronic kidney disease and the treatment protocol performed.
Citas
Assael, L. A. Oral bisphosphonates as a cause of bisphosphonate-related osteonecrosis of the jaws: clinical findings, assessment of risks, and preventive strategies. J. Oral Maxillofac. Surg., 67(5 Suppl.):35-43, 2009.
Chidambaram, R. Optimal Antibiotic Dosage for Chronic Kidney Disease Patient: A Pharmacological Manual for Oral Clinicians. Recent Pat. Antiinfect. Drug Discov., 10(2):113-23, 2015.
Di Fede, O.; Fusco, V.; Matranga, D.; Solazzo, L.; Gabriele, M.; Gaeta, G. M.; Favia, G.; Sprini, D.; Peluso, F.; Colella, G.; Vescovi, P. & Campisi, G. Osteonecrosis of the jaws in patients assuming oral bisphosphonates for osteoporosis: a retrospective multi-hospital-based study of 87 Italian cases. Eur. J. Int. Med., 24(8):784-90,2013.
Filho, J. Z. C.; Padilha, W. S. M. & dos Santos, E. K. N. Cuidados odontológicos em portadores de insuficiência renal crônica. Rev. Cir. Traumatol Buco-Maxilo-Fac. Camaragibe, 7(2):19-28, 2007.
Medeiros, N. H.; Neves, R. R. A.; Amorim, J. N. C. & Mendonça, S. M. S. D. A insuficiência renal crônica e suas interferências no atendimento odontológico – Revisão de literatura. Rev. Odontol. Univ. Cid. São Paulo, 26(3):232-42, 2015.
Otto, S.; Hafner, S.; Mast, G.; Tischer, T.; Volkmer, E.; Schieker, M.; Stürzenbaum, S. R.; von Tresckow, E.; Kolk, A.; Ehrenfeld, M. & Pautke, C. Bisphosphonate-related osteonecrosis of the jaw: is pH the missing part in the pathogenesis puzzle? J. Oral Maxillofac. Surg., 68(5):1158-61, 2010.
Ruggiero, S. L.; Dodson, T. B.; Assael, L. A.; Landesberg, R.; Marx, R. E.; Mehrotra, B. & American Association of Oral and Maxillofacial Surgeons. American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws--2009 update. J. Oral Maxillofac. Surg., 67(5 Suppl.):2-12, 2009.
Schiødt, M. Management of Osteonecrosis of the Jaw in Patients Receiving Antiresorptive Treatment. In: Silverman, S. L. & Abrahamsen, B. (Eds.). The Duration and Safety of Osteoporosis Treatment. Anabolic and Antiresorptive Therapy. 3th ed. New York, Springer International Publishing, 2016. pp.193-202.
Yamamoto, F. P. Estudo da Presença de Osteonecrose na Madíbula após Exodontia de Molares em Ratos Tratados com Alendronato de Sódio. PhD Thesis. São Paulo, Universidade de São Paulo, 2010.
Zanata, A.; Felin, G. C.; De Bona, M. C.; Sawazaki, R. & De Conto, F. Osteonecrose mandibular associada ao uso de bisfosfonato de sódio em paciente com mieloma múltiplo. Rev. Port. stomatol. Med. Dent. Cir. Maxilofac., 55(2):115-20, 2014.